Recent studies suggest that while high cholesterol is a known risk for cardiovascular disease, a diagnosis of high cholesterol may be associated with a lower mortality rate from lung, breast, prostate and bowel cancer, according to Science Daily.
Researchers have hypothesized that this may be due to the widespread use of cholesterol-lowering drugs – which may have protective effects against certain cancers.
According to the researchers, the protective effect is thought to be linked to treatments such as statins, which are given to people diagnosed with high cholesterol.
These medications can help reduce the risk of cancer or improve survival rates.
Research into the role of cholesterol in cancer development has also revealed that manipulating cholesterol levels can affect the growth of cancer cells, although this is not yet fully understood.
The link between high cholesterol and lower cancer mortality rates is not conclusive proof that high cholesterol itself is protective.
The protective effect may be due to the treatment patients receive after being diagnosed.
High cholesterol is a major risk factor for cardiovascular disease and is still considered a serious health concern – that must be managed with medication and lifestyle changes – to prevent heart attacks and strokes.
While the findings are promising, more research is needed to fully understand the relationship between high cholesterol, statin use, and cancer.